Medication protects fertility and defense system during chemotherapy

December 14, 2015

LOS ANGELES - While targeted cancer treatments have reduced side effects and improved efficacy, chemotherapy remains the backbone of combination therapies for many forms of cancer. Unfortunately, cancer patients may suffer from several side effects from chemotherapy, including infertility and a weakened defense system that makes them susceptible to life-threatening infections.

A study recently published by the journal, Endocrinology Today, holds hope for cancer patients undergoing chemotherapy to avoid two of the serious side effects and to stop cancer's growth.

Researchers at Los Angeles Biomedical Research Institute (LA BioMed) and the University of Southern California found the potent humanin analogue (HNG) protected male germ cells, which are essential to fertility, and white blood cells, which are the soldiers in the body's defense system, in cancer research models undergoing chemotherapy. The researchers also reported that HNG reduced metastases, or the spread of cancer cells to other organs in the body.

"Our study suggested that including HNG in chemotherapy may help cancer patients avoid infertility and a weakened defense system against infection while also increasing the effectiveness of the chemotherapy," said Christina Wang, MD, an LA BioMed researcher and corresponding author of the study. "More research is needed, and we are working diligently to fully document and understand the protective nature of HNG against the side effects of chemotherapy."

Recent advances in the understanding of cancer cell biology and the use of multiple types of treatments have led to improved cancer survival. But to improve the quality of life in cancer survivors, the researchers said there is an increasing need to protect the healthy cells from the toxic effects of chemotherapy without disrupting the treatment's effectiveness in reducing or eliminating cancer cells.

"Based on our findings, we also believe that HNG could protect other vital cells, including those in the heart and brain, which may be damaged by chemotherapy regimens," Dr. Wang said. "We will be conducting additional studies to determine how HNG can help guard against some of the most serious side effects of chemotherapy."
-end-
Research funding provided by UCLA Clinical and Translational Science Institute Grant UL1TR000124 (to LA BioMed and Harbor-UCLA Medical Center) and National Institutes of Health Grants R01AG034430, R01GM090311 and R01ES020812. Other researchers participating in the study from LA BioMed and Harbor-UCLA Medical Center were: YanHe Lue, Ronald Swerdloff, Samuel French, Vince Atienza, Victor Canela, Kevin W. Bruhn, Brian Stone and Yue Jia. USC researchers participating in the study were: Junxiang Wan, Jialin Xiao and Pinchas Cohen.

About LA BioMed

Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved diagnostics and treatments for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit http://www.LABioMed.org

LA BioMed

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.